About
Pursuing the dream of innovative drug discovery
with passionate and driven colleagues.
Voronoi, a KOSDAQ-listed biotechnology company headquartered in the Incheon Songdo Techno Park IT Center, is a global leader in the development of genotype directed kinase inhibitors for precision oncology.
Equipped with a state of the art research facility, Voronoi integrates comprehensive R&D capabilities spanning medicinal chemistry, pharmacology, DMPK, structural biology, molecular modeling, and in vivo pharmacology, enabling a fully integrated drug discovery platform.
Our Story